| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.997 | 0 | 0.997 | Antipruritic | 0.978 0.001 DBMET03675 0.948 0.001 DBMET02403 0.727 0.003 DBMET03674 | ||
| 0.996 | 0.002 | 0.996 | Toll-Like receptor 7 agonist | 0.995 0.002 DBMET03675 0.989 0.003 DBMET02403 0.971 0.003 DBMET03674 | ||
| 0.996 | 0.002 | 0.996 | Toll-Like receptor agonist | 0.995 0.002 DBMET03675 0.989 0.003 DBMET02403 0.971 0.003 DBMET03674 | ||
| 0.995 | 0.003 | 0.995 | Antiinflammatory | 0.991 0.003 DBMET03675 0.99 0.003 DBMET02403 0.983 0.004 DBMET03674 | ||
| 0.985 | 0 | 0.985 | Glucocorticoid agonist | 0.955 0 DBMET03675 0.919 0 DBMET02403 0.811 0.001 DBMET03674 | ||
| 0.974 | 0 | 0.974 | Corticosteroid-like | 0.881 0 DBMET03675 0.718 0 DBMET02403 0.478 0 DBMET03674 | ||
| 0.963 | 0 | 0.963 | Arachidonic acid antagonist | 0.73 0 DBMET03675 0.657 0 DBMET02403 0.435 0 DBMET03674 | ||
| 0.947 | 0.002 | 0.947 | Androgen antagonist | 0.744 0.002 DBMET03675 0.455 0.004 DBMET02403 0.29 0.008 DBMET03674 | ||
| 0.891 | 0 | 0.891 | Lipocortins synthesis agonist | 0.683 0 DBMET03675 0.645 0 DBMET02403 0.419 0 DBMET03674 | ||
| 0.825 | 0.001 | 0.825 | Glucocorticoid antagonist | 0.72 0.001 DBMET03675 0.675 0.001 DBMET02403 0.541 0.002 DBMET03674 | ||
| 0.742 | 0.004 | 0.979 | Hypoxia-inducible factor 1 alpha inhibitor | 0.517 0.013 DBMET03675 0.979 0.002 DBMET02403 0.844 0.003 DBMET03674 | DBMET02403 | |
| 0.726 | 0.005 | 0.762 | Immunosuppressant | 0.686 0.005 DBMET03675 0.762 0.004 DBMET02403 0.723 0.005 DBMET03674 | DBMET02403 | |
| 0.561 | 0.002 | 0.561 | Mineralocorticoid receptor antagonist | 0.542 0.003 DBMET03675 0.157 0.005 DBMET02403 0.122 0.006 DBMET03674 | ||
| 0.423 | 0.002 | 0.823 | Androgen agonist | 0.212 0.004 DBMET03675 0.823 0.001 DBMET02403 0.457 0.002 DBMET03674 | DBMET02403 | |
| 0.422 | 0.01 | 0.58 | Interferon gamma antagonist | 0.36 0.013 DBMET03675 0.58 0.003 DBMET02403 0.551 0.004 DBMET03674 | DBMET02403 | |
| 0.375 | 0.009 | 0.652 | NOS3 expression enhancer | 0.447 0.006 DBMET03675 0.582 0.004 DBMET02403 0.652 0.004 DBMET03674 | DBMET03674 | |
| 0.385 | 0.027 | 0.484 | Nitric oxide antagonist | 0.376 0.028 DBMET03675 0.484 0.017 DBMET02403 0.48 0.017 DBMET03674 | DBMET02403 | |
| 0.344 | 0.014 | 0.423 | Lipocortins synthesis antagonist | 0.38 0.01 DBMET03675 0.388 0.009 DBMET02403 0.423 0.007 DBMET03674 | DBMET03674 | |
| 0.326 | 0.007 | 0.681 | Interleukin 4 antagonist | 0.376 0.005 DBMET03675 0.63 0.004 DBMET02403 0.681 0.003 DBMET03674 | DBMET03674 | |
| 0.319 | 0.005 | 0.319 | Aromatase inhibitor | 0.208 0.008 DBMET03675 0.317 0.005 DBMET02403 0.206 0.008 DBMET03674 | ||
| 0.34 | 0.08 | 0.686 | Transcription factor NF kappa B inhibitor | 0.472 0.049 DBMET03675 0.568 0.035 DBMET02403 0.686 0.022 DBMET03674 | DBMET03674 | |
| 0.244 | 0.005 | 0.482 | Interleukin 5 antagonist | 0.296 0.004 DBMET03675 0.419 0.003 DBMET02403 0.482 0.003 DBMET03674 | DBMET03674 | |
| 0.245 | 0.044 | 0.283 | Hepatoprotectant | 0.211 0.058 DBMET03675 0.283 0.035 DBMET02403 0.242 0.045 DBMET03674 | DBMET02403 | |
| 0.156 | 0.015 | 0.223 | Anabolic | 0.182 0.007 DBMET03675 0.194 0.005 DBMET02403 0.223 0.003 DBMET03674 | DBMET03674 | |
| 0.168 | 0.092 | 0.477 | P-glycoprotein inhibitor | 0.286 0.032 DBMET03675 0.272 0.035 DBMET02403 0.477 0.01 DBMET03674 | DBMET03674 | |
| 0.09 | 0.015 | 0.104 | Nitric oxide donor | 0.099 0.009 DBMET03675 0.096 0.01 DBMET02403 0.104 0.007 DBMET03674 | DBMET03674 | |
| 0.092 | 0.034 | 0.121 | T cell inhibitor | 0.092 0.034 DBMET03675 0.119 0.014 DBMET02403 0.121 0.014 DBMET03674 | DBMET03674 | |
| 0.056 | 0.016 | 0.271 | Progesterone antagonist | 0.056 0.016 DBMET03675 0.27 0.004 DBMET02403 0.271 0.004 DBMET03674 | DBMET03674 | |
| 0.044 | 0.005 | 0.073 | Progesterone agonist | 0.034 0.006 DBMET03675 0.073 0.004 DBMET02403 0.052 0.004 DBMET03674 | DBMET02403 | |
| 0.21 | 0.175 | 0.367 | Sodium/bile acid cotransporter inhibitor | 0.317 0.065 DBMET03675 0.299 0.08 DBMET02403 0.367 0.03 DBMET03674 | DBMET03674 | |
| 0.107 | 0.081 | 0.139 | Estrogen antagonist | 0.12 0.055 DBMET03675 0.126 0.044 DBMET02403 0.139 0.029 DBMET03674 | DBMET03674 | |
| 0.036 | 0.018 | 0.047 | RNA-directed RNA polymerase stimulant | 0.04 0.016 DBMET03675 0.042 0.016 DBMET02403 0.047 0.014 DBMET03674 | DBMET03674 | |
| 0.003 | 0.009 | 0.014 | Transcortin receptor antagonist | 0.005 0.004 DBMET03675 0.007 0.003 DBMET02403 0.014 0.002 DBMET03674 | DBMET03674 | |
| 0.037 | 0.047 | 0.051 | Microtubule stabilization | 0.047 0.031 DBMET02403 0.051 0.027 DBMET03674 | DBMET03674 | |
| 0.03 | 0.057 | 0.081 | Estrogen agonist | 0.047 0.037 DBMET03675 0.049 0.036 DBMET02403 0.081 0.023 DBMET03674 | DBMET03674 | |
| 0.026 | 0.093 | 0.037 | Glucose-6-phosphate dehydrogenase inhibitor | 0.037 0.027 DBMET03674 | DBMET03674 | |
| 0.127 | 0.198 | 0.304 | Antioxidant | 0.178 0.134 DBMET03675 0.239 0.09 DBMET02403 0.304 0.06 DBMET03674 | DBMET03674 | |
| 0.036 | 0.13 | 0.076 | Na+ K+ transporting ATPase inhibitor | 0.076 0.054 DBMET02403 | DBMET02403 | |
| 0.059 | 0.202 | 0.148 | Microtubule formation inhibitor | 0.127 0.053 DBMET02403 0.148 0.038 DBMET03674 | DBMET03674 | |
| 0.051 | 0.199 | 0.092 | Estrogen receptor beta antagonist | 0.092 0.079 DBMET03674 | DBMET03674 | |
| 0.024 | 0.208 | 0.068 | Glucose-6-phosphate translocase inhibitor | 0.06 0.024 DBMET02403 0.068 0.017 DBMET03674 | DBMET03674 | |
| 0.042 | 0.268 | 0.15 | Thrombolytic | 0.134 0.095 DBMET02403 0.15 0.082 DBMET03674 | DBMET03674 | |
| 0.071 | 0.297 | 0.132 | Sphingosine 1-phosphate receptor 2 agonist | 0.105 0.086 DBMET03675 0.132 0.04 DBMET03674 | DBMET03674 | |
| 0.034 | 0.346 | 0.11 | Lipid peroxidase inhibitor | 0.11 0.104 DBMET03674 | DBMET03674 | |
| 0.004 | 0.326 | 0.043 | 5-Alpha-reductase inhibitor | 0.043 0.022 DBMET03674 | DBMET03674 | |
| 0.041 | 0.401 | 0.12 | Farnesoid X receptor antagonist | 0.12 0.105 DBMET03674 | DBMET03674 | |
| 0.075 | 0.546 | 0.373 | Apoptosis agonist | 0.256 0.208 DBMET02403 0.373 0.127 DBMET03674 | DBMET03674 | |
| 0.028 | 0.513 | 0.182 | Cytokine production inhibitor | 0.182 0.043 DBMET02403 | DBMET02403 | |
| 0.005 | 0.507 | 0.067 | HIV-1 integrase (Strand Transfer) inhibitor | 0.067 0.037 DBMET03674 | DBMET03674 | |
| 0.008 | 0.548 | 0.075 | Inducible nitric-oxide synthase inhibitor | 0.075 0.072 DBMET03674 | DBMET03674 | |
| 0.02 | 0.594 | 0.133 | Interleukin antagonist | 0.133 0.132 DBMET03674 | DBMET03674 | |
| 0.02 | 0.623 | 0.185 | DNA synthesis inhibitor | 0.185 0.147 DBMET02403 | DBMET02403 | |
| 0.005 | 0.61 | 0.059 | HIV-1 integrase (3'-Processing) inhibitor | 0.059 0.049 DBMET03674 | DBMET03674 | |
| 0.036 | 0.76 | 0.251 | Apoptosis antagonist | 0.251 0.126 DBMET03674 | DBMET03674 | |
| 0.012 | 0.781 | 0.252 | Antibacterial | 0.252 0.175 DBMET03674 | DBMET03674 | |
| 0.015 | 0.828 | 0.27 | Cyclophilin D inhibitor | 0.27 0.191 DBMET02403 | DBMET02403 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |